No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas.
De Preter
Katleen
K
Speleman
Frank
F
Combaret
Valérie
V
Lunec
John
J
Board
Julian
J
Pearson
Andy
A
De Paepe
Anne
A
Van Roy
Nadine
N
Laureys
Geneviève
G
Vandesompele
Jo
J
D053487:DEAD-box RNA Helicases; D005500:Follow-Up Studies; D005784:Gene Amplification; D006801:Humans; D000071447:N-Myc Proto-Oncogene Protein; D009447:Neuroblastoma / Q000235:genetics*; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D011237:Predictive Value of Tests; D011379:Prognosis; D020365:RNA Helicases / Q000235:genetics*; D012189:Retrospective Studies; D016019:Survival Analysis
C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; C086252:DDX1 protein, human; D053487:DEAD-box RNA Helicases; D020365:RNA Helicases